<DOC>
	<DOCNO>NCT01871987</DOCNO>
	<brief_summary>A study evaluate effect food plasma concentration change quetiapine oral administration FK949E ( extended release formulation quetiapine ) healthy male subject .</brief_summary>
	<brief_title>Study Evaluate Effect Food Intake Plasma Concentration Changes Quetiapine After Oral Administration FK949E Healthy Volunteers</brief_title>
	<detailed_description>This 3-way cross-over study .</detailed_description>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Body weight : ≥50.0 kg , &lt; 85.0 kg Body Mass Index : ≥17.6 , &lt; 26.4 Healthy , judge investigator/subinvestigator base result physical examination ( subjective symptom objective finding ) test obtain screen period hospital admission Period 1 immediately study medication Subjects follow history . 1 . Hepatic disease ( e.g . viral hepatitis , druginduced liver injury ) . 2 . Heart disease ( e.g . congestive heart failure , angina pectoris , arrhythmia require treatment ) . 3 . Respiratory disease ( e.g . serious bronchial asthma , chronic bronchitis ) 4 . Gastrointestinal disease ( e.g . serious peptic ulcer , gastroesophageal reflux esophagitis ; diseases require several selection except appendicitis ) 5 . Renal disease ( e.g . acute renal failure , glomerulonephritis , interstitial nephritis ) . 6 . Cerebrovascular disorder ( e.g . cerebral infarction ) . 7 . Malignant tumor . 8 . Drug allergy . Allergic disorder ( except hay fever ) 9 . Any use drug abuse . Alcohol abuse Any concurrent illness ( except caries ) A deviation normal reference range blood pressure , pulse rate , body temperature , 12lead ECG screen upon admission Period 1 ( day precede day study medication ) . Any deviation follow criterion clinical laboratory test screen upon admission Period 1 ( day precede day study medication ) . The normal reference range specify study site use normal reference range present study . 1 . Hematology : A deviation ±20 % upper low limit normal range 2 . Blood biochemistry : A deviation normal range AST , ALT , creatinine ( Cre ) , serum electrolyte . A deviation ±20 % upper low limit normal range item . However , low limit normal range establish item deviation low limit consider clinically significant [ AST , ALT , total bilirubin ( TBil ) , ALP , γGTP , LDH , CK , Cre , uric acid ( UA ) total cholesterol ( TCho ) ] . 3 . Urinalysis : UGlu , UPro ≥+1 UUro ≥+2 4 . Urinary drug test : A positive result phencyclidine , benzodiazepine , cocaine , amphetamine , cannabis , opiates , barbiturates tricyclic antidepressant 5 . Immunological test : A positive result HBs antigen , HCV antibody , syphilis , HIV antigen/antibody Received medication within 14 day hospital admission Period 1 schedule receive medication Received investigational drug clinical postmarketing study within 120 day screen assessment Previous treatment FK949E Donated 400 mL whole blood within 90 day , 200 mL whole blood within 30 day , blood component within 14 day screen assessment Excessive smoking drinking habit ( measure `` excessive '' : alcohol : 45 g/day [ 633 mL bottle beer contain 25 g alcohol , 180 mL Japanese sake contain 22 g alcohol ] , smoking : 20 cigarettes/day ) . Other subject concern ineligible investigator/subinvestigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>FK949E</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Antipsychotic</keyword>
</DOC>